Business
from24/7 Wall St.
5 days agoVanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion
Concentrated exposure to GLP-1 leaders drove PPH's gains, but rising competition, pricing pressure, and concentration risk threaten future performance.